Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
|colspan="1" style = "background:#66e0ff;color:black; font-size:80%"|20:40 '''wk''' | |colspan="1" style = "background:#66e0ff;color:black; font-size:80%"|20:40 '''wk''' | ||
|colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 | |colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 | ||
|colspan="1" style = "background:# | |colspan="1" style = "background:#66e0ff;color:black; font-size:80%"|20:40 '''wk''' | ||
|colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 | |colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 | ||
|colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 '''stg''' | |colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 '''stg''' | ||
Revision as of 00:15, 22 June 2023
| Immunophenotype LPD | |||||
|---|---|---|---|---|---|
| Marker | CLL | MCL | FL | MZL | HCL |
| κ/λ | 40:80 wk | >80 | 40:80 var | >80 | >80 stg |
| FMC7 | 20:40 wk | 40:80 | 20:40 wk | 40:80 | 40:80 stg |
| CD5 | >80 | >80 longer | <5% | ||
| CD10 | 5-20 | 5-20 | >80 Stg | ||
| CD11C | 20:40 wk | 20:40 wk | <5% | ||
| CD19 | >80 | >80 | 40:80 | ||
| CD20 | >80 | >80 | >80 | ||
| CD23 | >80 | 5-20 | 40:80 | ||
| CD25 | 20:40 wk | 20:40 wk | 5-20 wk | ||
| CD38 | 20:40 | >80 | >80 | ||
| CD43 | >80 | 40:80 | <5% | ||
| CD79b | >80 wk | >80 | >80 | ||
| CD103 | <5% | <5% | <5% | ||
| CD138 | <5% | <5% | <5% | ||
| CD200 | >80 | <5% | <5% | ||
Key to table:
Key to colour code Click for link
Key to expression code Click for link